This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition

Title Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition
Abstract

We report the identification of two subsets of fluorinated nonxanthine A 2B adenosine receptor antagonists. The novel derivatives explore the effect of fluorination at different positions of two pyrimidine-based scaffolds. The most interesting ligands combine excellent hA 2B affinity ( K i 2B receptor, and we herein provide refinement of such models with the fluorinated compounds, which allows the explanation of the spurious effects of the fluorination at the different positions explored. These models are importantly confirmed by a synergistic study combining chiral HPLC, circular dichroism, diastereoselective synthesis, molecular modeling, and X-ray crystallography, providing experimental evidence toward the stereospecific interaction between optimized trifluorinated stereoisomers and the hA 2B receptor.

Apa Reference Mallo-Abreu, A., Majellaro, M., Jespers, W., Azuaje, J., Caamaño, O., García-Mera, X., Brea, J. M., Loza, M. I., Gutiérrez-de-Terán, H., & Sotelo, E. (2019). Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition. Journal of Medicinal Chemistry, 62(20), 9315–9330. 10.1021/acs.jmedchem.9b01340
Doi 10.1021/acs.jmedchem.9b01340
Publication Date 26 Sep 2019
Publication Type Article
Researcher Hugo Gutiérrez de Terán Castañón
Ontology Genome Assembly, Experimental structure determination, Molecular Interactions/Docking
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home